Moreover, TIPE2 suppressed tumor invasiveness and angiogenesis via inhibiting the activation of Rac1 and subsequently weakening its downstream effects, F-actin polymerization and VEGF expression. The gene discussed is TIPE2; the disease is neoplasm.